Adherence of SARS-CoV-2 Seroepidemiologic Studies to the ROSES-S Reporting Guideline During the COVID-19 Pandemic.

Brianna ChengEmma LoeschnikAnabel Selemon Reza HosseiniJane YuanHarriet WareXiaomeng MaChristian CaoIsabel BergeriLorenzo SubissiHannah C LewisTyler WilliamsonPaul RonksleyRahul K AroraMairead WhelanNiklas Bobrovitz

Published in: Influenza and other respiratory viruses (2024)

Completeness of reporting in SARS-CoV-2 seroepidemiologic studies was suboptimal. Publication of the ROSES-S guideline was not associated with changes in reporting practices. Authors should improve adherence to the ROSES-S guideline with support from stakeholders.

Keyphrases

sars cov
adverse drug
respiratory syndrome coronavirus
case control
healthcare
emergency department
type diabetes